---
title: 'Transplantation in Adult Patients with Epstein-Barr Virus-Associated Hemophagocytic
  Lymphohistiocytosis: Yes or No?'
date: '2024-08-02'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39093986/?utm_source=curl&utm_medium=rss&utm_campaign=journals&utm_content=7603509&fc=None&ff=20240803181345&v=2.18.0.post9+e462414
source: Blood
description: Hemophagocytic lymphohistiocytosis (HLH) is a syndrome characterized
  by aberrant immunological activity with a dismal prognosis. Epstein-Barr virus-associated
  HLH (EBV-HLH) is the most common type among adults. Patients with EBV infection
  to B cells could benefit from rituximab, whereas lethal outcomes may occur in patients
  with EBV infection to T cells, nature killer (NK) cells, or multilineages. The necessity
  of allogeneic hematopoietic stem cell transplantation (HSCT) in adult ...
disable_comments: true
---
Hemophagocytic lymphohistiocytosis (HLH) is a syndrome characterized by aberrant immunological activity with a dismal prognosis. Epstein-Barr virus-associated HLH (EBV-HLH) is the most common type among adults. Patients with EBV infection to B cells could benefit from rituximab, whereas lethal outcomes may occur in patients with EBV infection to T cells, nature killer (NK) cells, or multilineages. The necessity of allogeneic hematopoietic stem cell transplantation (HSCT) in adult ...